Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 3 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar 3rdChanceTom (71.31) Submitted: 11/8/2012 9:24:26 PM : Outperform Start Price: $44.55 MRK Score: +4.17

This company is the result of the merger of Merck(Old) and Schering-Plough in 2009. It is too young for me to properly and predictively evaluate.
Tom

Featured Broker Partners


Advertisement